Cardinal Health Inc. is a nation-wide drug distributor and provider of services to pharmacies, healthcare providers and manufacturers. The company has two reporting segments: Pharmaceutical and Medical. The Pharmaceutical segment is the second largest pharmaceutical distributor in the United States and the largest nuclear pharmacy. Its products and services include pharmaceutical distribution, manufacturer and specialty services, and nuclear and pharmacy services. The Medical segment manufactures products such as single-use surgical drapes, gowns and apparel; exam and surgical gloves; and fluid suction and collection systems and offers sterile and non-sterile procedure kits. These products are sold directly or distributed via third-party sources in the U.S., Canada, Europe, South America and the Asia/Pacific.?
Revenue (Most Recent Fiscal Year) | $226.83B |
Net Income (Most Recent Fiscal Year) | $852.00M |
PE Ratio (Current Year Earnings Estimate) | 17.85 |
PE Ratio (Trailing 12 Months) | 20.62 |
PEG Ratio (Long Term Growth Estimate) | 1.63 |
Price to Sales Ratio (Trailing 12 Months) | 0.18 |
Price to Book Ratio (Most Recent Quarterly Book Value per Share) | -- |
Price to Cash Ratio (Most Recent Annual Cash Flow per Share) | 15.66 |
Pre-Tax Margin (Trailing 12 Months) | 0.95% |
Net Margin (Trailing 12 Months) | 0.70% |
Return on Equity (Trailing 12 Months) | -68.84% |
Return on Assets (Trailing 12 Months) | 4.21% |
Current Ratio (Most Recent Fiscal Quarter) | 0.94 |
Quick Ratio (Most Recent Fiscal Quarter) | 0.50 |
Debt to Common Equity (Most Recent Fiscal Quarter) | -- |
Inventory Turnover (Trailing 12 Months) | 13.48 |
Book Value per Share (Most Recent Fiscal Quarter) | $-13.19 |
Earnings per Share (Most Recent Fiscal Quarter) | $2.35 |
Earnings per Share (Most Recent Fiscal Year) | $7.53 |
Diluted Earnings per Share (Trailing 12 Months) | $6.41 |
Exchange | NYSE |
Sector | Healthcare |
Industry | Medical Distribution |
Common Shares Outstanding | 238.68M |
Free Float | 238.46M |
Market Capitalization | $39.37B |
Average Volume (Last 20 Days) | 2.42M |
Beta (Past 60 Months) | 0.68 |
Percentage Held By Insiders (Latest Annual Proxy Report) | 0.09% |
Percentage Held By Institutions (Latest 13F Reports) | 87.17% |
Annual Dividend (Based on Last Quarter) | $2.04 |
Dividend Yield (Based on Last Quarter) | 1.24% |